Could a simple shot replace IV drips for nausea?
NCT ID NCT02466984
First seen May 20, 2026 · Last updated Jun 19, 2026 · Updated 7 times
Summary
This study looked at whether metoclopramide, a common anti-nausea drug, works as well when injected under the skin (subcutaneous) as when given through a vein (IV). Five patients in a palliative care unit received the drug both ways to compare absorption. The goal is to offer a more comfortable and convenient option for managing nausea and vomiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VOMITING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier Universitaire de Bordeaux - St André
Bordeaux, Aquitaine, 33000, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
metoclopramide (Primperan)
What this could lead to
If it works, this could provide a simpler, less invasive way to give metoclopramide for nausea and vomiting in patients who cannot take oral medication.
What could go wrong
This is a very small study (5 participants) in a specific palliative care setting, so results may not apply broadly. The drug's effectiveness via subcutaneous route is still unproven.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.